Price alert —
Sign in to get a one-time email the moment CCEL crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · CCEL
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-05-31 | $0.0B | $0.0B | $0.0B | $0.0B | 7.1% | 15.4% |
| 2026-02-28 | $0.0B | $0.0B | $0.0B | $0.0B | 0.6% | 10.0% |
| 2025-11-30 | $0.0B | $-0.0B | $0.0B | $0.0B | -48.7% | 5.0% |
| 2025-05-31 | $0.0B | $0.0B | $0.0B | $0.0B | 4.5% | 18.8% |
| 2025-02-28 | $0.0B | $0.0B | $0.0B | $0.0B | 3.5% | 13.3% |
| 2024-11-30 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare CCEL vs peers
Line CCEL up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with CCEL
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 17 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-07-15 | 0.07 | — | — | -2.8% |
| 2026-04-14 | 0.02 | -0.02 | +195.0% | +1.1% |
| 2026-02-27 | -0.47 | -0.09 | -417.3% | -3.5% |
| 2025-10-15 | 0.10 | -0.03 | +419.0% | -1.1% |
| 2025-07-15 | 0.05 | -0.04 | +217.0% | +0.0% |
| 2025-04-14 | 0.05 | 0.01 | +437.0% | -1.1% |
| 2025-02-28 | -0.25 | 0.02 | -1372.5% | -14.9% |
| 2024-10-15 | 0.14 | 0.03 | +376.7% | +7.0% |
| 2024-07-15 | 0.10 | 0.05 | +92.3% | +0.8% |
| 2024-04-15 | 0.09 | -0.01 | +1031.0% | -5.4% |
| 2024-02-28 | 0.08 | -0.07 | +218.6% | +3.0% |
| 2023-10-12 | 0.09 | -0.05 | +282.0% | -2.2% |
| 2023-07-14 | 0.02 | -0.07 | +135.4% | -9.5% |
| 2023-04-21 | 0.08 | -0.03 | +360.7% | +14.8% |
| 2023-02-28 | 0.14 | -0.01 | +1490.0% | +0.0% |
| 2022-10-14 | 0.05 | — | — | -2.9% |
| 2006-10-16 | -0.08 | 0.03 | -366.7% | — |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| CCEL ★ | $0B | — | 173.0 | 0.9 | 38.7 | -1.5 | 63.9% | -1.9% | 72.1% | 5.86% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.2 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 4.72%
| Holder | Shares | % out |
|---|---|---|
| SFI Advisors, LLC | 165,300 | 1.46% |
| Vanguard Capital Management LLC | 161,524 | 1.43% |
| MassMutual Private Wealth & Trust, F | 111,035 | 0.98% |
| Geode Capital Management, LLC | 43,616 | 0.39% |
| Vanguard Fiduciary Trust Co | 23,346 | 0.21% |
| Blackrock Inc. | 13,983 | 0.12% |
| Susquehanna International Group, LLP | 10,018 | 0.09% |
| Osaic Holdings Inc. | 2,500 | 0.02% |
| UBS Group AG | 672 | 0.01% |
| Morgan Stanley | 601 | 0.01% |
Insider activity · 90d
0 buys / 0 sells · ratio 0.0 · Finnhub
- TAYMANS JILL M M 0 @ $3.10
- TAYMANS JILL M M 52,896 @ $3.10
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 10-Q | 2026-07-15 | 10-Q | view · |
| 4 | 2026-05-29 | 4 | view · |
| 8-K | 2026-05-08 | 8-K | view · |
| 10-Q | 2026-04-14 | 10-Q | view · |
| 8-K | 2026-03-12 | 8-K | view · |
| 10-K | 2026-02-27 | 10-K | view · |
| 4 | 2026-01-09 | 4 | view · |
| 4 | 2026-01-09 | 4 | view · |
| 4 | 2026-01-09 | 4 | view · |
| 4 | 2026-01-09 | 4 | view · |
| 4 | 2025-11-24 | 4 | view · |
| 4 | 2025-11-19 | 4 | view · |
| 4 | 2025-11-12 | 4 | view · |
| 8-K | 2025-11-12 | 8-K | view · |
| 4 | 2025-11-04 | 4 | view · |
| 8-K | 2025-10-23 | 8-K | view · |
| 4 | 2025-10-23 | 4 | view · |
| 4 | 2025-10-23 | 4 | view · |
| 10-Q | 2025-10-15 | 10-Q | view · |
| DEF 14A | 2025-09-26 | DEF 14A | view · |
| 4 | 2025-09-18 | 4 | view · |
| 4 | 2025-09-10 | 4 | view · |
| 8-K | 2025-09-10 | 8-K | view · |
| 4 | 2025-09-02 | 4 | view · |
| 4 | 2025-08-27 | 4 | view · |
| 4 | 2025-08-19 | 4 | view · |
| 4 | 2025-08-18 | 4 | view · |
| 10-Q | 2025-07-15 | 10-Q | view · |
| 4 | 2025-07-10 | 4 | view · |
| 8-K | 2025-05-22 | 8-K | view · |
| 8-K | 2025-05-08 | 8-K | view · |
| 10-Q | 2025-04-14 | 10-Q | view · |
| 10-K | 2025-02-28 | 10-K | view · |
| 4 | 2025-01-23 | 4 | view · |
| 4 | 2025-01-23 | 4 | view · |
| 4 | 2025-01-23 | 4 | view · |
| 4 | 2025-01-23 | 4 | view · |
| 4 | 2024-11-14 | 4 | view · |
| 4 | 2024-10-31 | 4 | view · |
| 8-K | 2024-10-31 | 8-K | view · |
| 8-K | 2024-10-30 | 8-K | view · |
| 8-K | 2024-10-17 | 8-K | view · |
| 10-Q | 2024-10-15 | 10-Q | view · |
| DEF 14A | 2024-10-07 | DEF 14A | view · |
| 8-K | 2024-09-17 | 8-K | view · |
| 10-Q | 2024-07-15 | 10-Q | view · |
| 10-Q | 2024-04-15 | 10-Q | view · |
| 8-K | 2024-03-26 | 8-K | view · |
| 10-K | 2024-02-28 | 10-K | view · |
| 4 | 2023-12-28 | FORM 4 SUBMISSION | view · |
| 4 | 2023-12-28 | FORM 4 SUBMISSION | view · |
| 4 | 2023-12-28 | FORM 4 SUBMISSION | view · |
| 4 | 2023-12-28 | FORM 4 SUBMISSION | view · |
| 10-Q | 2023-10-12 | 10-Q | view · |
| 4 | 2023-10-12 | FORM 4 SUBMISSION | view · |
| 8-K | 2023-10-12 | 8-K | view · |
| DEF 14A | 2023-09-14 | DEF 14A | view · |
| 8-K | 2023-08-25 | 8-K | view · |
| 10-Q | 2023-07-14 | 10-Q | view · |
| 10-Q | 2023-04-21 | 10-Q | view · |
About CCEL
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Options picks · CCEL
ITM + OTM ideas from the latest scanLoading…
Congress trades · CCEL
STOCK Act disclosuresLoading…
SEC filings & insiders · CCEL
EDGAR · liveLoading…
Holders · CCEL
Institutions & insider activityLoading…